We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.65B
AUM Growth
+$414M
(+4.5%)
Cap. Flow
+$77.2M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
20.18%
Holding
1,150
New
121
Increased
363
Reduced
495
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$53.4M |
| 2 |
Occidental Petroleum
OXY
|
+$38M |
| 3 |
Capital One
COF
|
+$36.7M |
| 4 |
Elevance Health
ELV
|
+$27.1M |
| 5 |
Kroger
KR
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Align Technology
ALGN
|
+$43.2M |
| 2 |
Microsoft
MSFT
|
+$36.6M |
| 3 |
Qualcomm
QCOM
|
+$34.8M |
| 4 |
Mastercard
MA
|
+$33.6M |
| 5 |
Merck
MRK
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Healthcare | 14.84% |
| 3 | Consumer Discretionary | 14.57% |
| 4 | Financials | 13.21% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
TriNet
TNET
$3.12B
| $24.5M | 0.25% |
413,837
+106,073
| +34% | +$6.81M |
|
102
LivaNova
LIVN
$4.49B
| $24.4M | 0.25% |
539,728
+51,164
| +10% | +$2.48M |
|
103
ICU Medical
ICUI
$4.14B
| $24.1M | 0.25% |
131,687
-57,983
| -31% | -$10.9M |
|
104
NRG Energy
NRG
$27.1B
| $23.5M | 0.24% |
765,054
+17,896
| +2% | +$591K |
|
|
BLUE
105
DELISTED
bluebird bio
BLUE
| $23.4M | 0.24% |
33,535
+13,109
| +64% | +$10.2M |
|
106
LPL Financial
LPLA
$27.1B
| $23.2M | 0.24% |
302,990
+7,674
| +3% | +$609K |
|
107
Alkermes
ALKS
$8.44B
| $23.2M | 0.24% |
1,399,702
+216,394
| +18% | +$3.93M |
|
108
Equity Lifestyle Properties
ELS
$12.9B
| $22.7M | 0.24% |
370,819
-17,914
| -5% | -$1.16M |
|
109
Meta Platforms (Facebook)
META
$1.51T
| $22.6M | 0.23% |
86,485
+3,006
| +4% | +$775K |
|
110
FMC
FMC
$1.41B
| $22.3M | 0.23% |
210,880
+6,598
| +3% | +$706K |
|
|
NEWR
111
DELISTED
New Relic, Inc.
NEWR
| $22.3M | 0.23% |
394,811
+64,270
| +19% | +$3.92M |
|
112
Pinnacle West Capital
PNW
$12.9B
| $21.6M | 0.22% |
289,910
+18,379
| +7% | +$1.41M |
|
|
MDRX
113
DELISTED
Veradigm Inc. Common Stock
MDRX
| $21.3M | 0.22% |
2,620,091
-77,617
| -3% | -$634K |
|
114
Valero Energy
VLO
$89.4B
| $21.1M | 0.22% |
486,747
+20,088
| +4% | +$1.05M |
|
|
VRNT
115
DELISTED
Verint Systems
VRNT
| $21M | 0.22% |
854,247
+293,703
| +52% | +$6.85M |
|
|
WCC
116
WESCO International
WCC
$16B
| $20.9M | 0.22% |
475,448
+29,304
| +7% | +$1.25M |
|
117
Celanese
CE
$4.87B
| $20.5M | 0.21% |
190,698
-47,762
| -20% | -$4.77M |
|
118
Visteon
VC
$2.87B
| $20M | 0.21% |
289,044
+134,169
| +87% | +$9.91M |
|
119
O-I Glass
OI
$1.44B
| $20M | 0.21% |
1,888,510
+158,542
| +9% | +$1.69M |
|
120
State Street
STT
$49.8B
| $20M | 0.21% |
336,913
-34,701
| -9% | -$2.25M |
|
121
Arista Networks
ANET
$210B
| $19.8M | 0.21% |
1,533,568
+25,520
| +2% | +$351K |
|
|
SRC
122
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $19.8M | 0.21% |
587,638
-126,316
| -18% | -$4.4M |
|
123
Sonos
SONO
$1.9B
| $19.4M | 0.2% |
1,277,005
-81,096
| -6% | -$1.19M |
|
124
Herbalife
HLF
$1.29B
| $18.8M | 0.2% |
403,274
+2,831
| +0.7% | +$139K |
|
125
Louisiana-Pacific
LPX
$5.36B
| $18.7M | 0.19% |
635,331
-123,946
| -16% | -$3.81M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2020 Portfolio in Review
As of Q3 2020, Jacobs Levy Equity Management held 1,150 positions worth $9.65B, up 4.5% from $9.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management's Q3 2020 filing shows 121 new, 363 increased, 495 reduced and 137 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M. The largest sale was Align Technology, an estimated $43.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M.
- Jacobs Levy Equity Management added most to Lowe's Companies in Q3 2020, an estimated $53.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2020 reduction was Align Technology, cutting an estimated $43.2M.
- Jacobs Levy Equity Management fully exited Cloudera, Inc. in Q3 2020, selling an estimated $17.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $9.65B portfolio in Q3 2020.
- Jacobs Levy Equity Management opened 121 new positions and closed 137 in Q3 2020.
- Jacobs Levy Equity Management's portfolio value rose 4.5% quarter-over-quarter to $9.65B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.